Skip to content
GLP-1 Scorecard
Menu
Site position #180

OurView Health

Published by GLP-1 ScorecardUpdated

OurView (OurView Health) is a 100% online multi-vertical telehealth service with an Our View Savings Club membership offering pharmacy-direct pricing on U.S.-compounded medications.

Visit OurView HealthWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$75/mo (starting dose, compounded)
Tirzepatide
$135/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh OurView Health against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value76/100
Dose & formulation64/100
Clinical oversight79/100
Labs & monitoring53/100
Fulfillment70/100
Contract terms45/100

Strengths

  • Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
  • Clear product pricing with no contracts; medication shipped to your door (30-day supply)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
  • Discloses meds are compounded by a licensed third-party pharmacy; multi-vertical (TRT, HRT, BHRT, peptides)

What to consider

  • A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
  • Both figures are starting-dose rates; the cost of a titrated dose is published as a ladder rather than a single price
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Bottom line — Grade C

Best for: Shoppers who want budget shoppers wanting low-cost compounded GLP-1 via a membership savings model.

Site position #180 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest OurView Health — the realistic shortlist.

The 20 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect OurView Health's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on OurView Health's site. Not medical advice; see our disclosure.

← Back to the scorecard